Our Blog
Insights on regulatory affairs, quality, pharmacovigilance and RNA technologies from the Molgenium team.
CMC & Product Development
Analytics Over Trials: The New Biosimilar Pathway and What It Means for CMC
By Dr. Mohamad Toutounji
Sep 22, 2026
Advanced Therapies (ATMPs & mRNA)
In Vivo CAR-T: When the Cell Factory Moves Inside the Patient
By Dr. Mohamad Toutounji
Sep 08, 2026